| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| May 18, 2022 | Grant(A) | 2.1M | — | — | 2.1M |
| May 18, 2022 | Disposed to issuer(D) | 2.1M | — | — | 0 |
| May 18, 2022 | Grant(A) | 2.4M | — | — | 2.4M |
| May 18, 2022 | Grant(A) | 4.8M | — | — | 4.8M |
| May 18, 2022 | Grant(A) | 4.6M | — | — | 4.6M |
| May 18, 2022 | Grant(A) | 10.6M | — | — | 10.6M |
| May 18, 2022 | Disposed to issuer(D) | 4.6M | — | — | 0 |
| May 18, 2022 | Grant(A) | 3.2M | — | — | 3.2M |
| May 18, 2022 | Disposed to issuer(D) | 3.2M | — | — | 0 |
| May 18, 2022 | Grant(A) | 10.6M | — | — | 10.6M |
| May 18, 2022 | Disposed to issuer(D) | 4.8M | — | — | 0 |
| May 18, 2022 | Disposed to issuer(D) | 2.4M | — | — | 0 |
Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-22-018968) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for TENAX THERAPEUTICS, INC.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.